JUL 06, 2016 4:38 AM PDT

Cancer and Addiction May Share a Common Drug

WRITTEN BY: Xuan Pham
Researchers from the University of London have found that a drug used to combat addiction may also be effective at killing cancer cells. The discovery has wide implications for cancer treatment, given that the drug of interest is naltrexone, a drug widely prescribed for addicts.
 
Drug that helps addicts may help treat cancer too | Image: pixabay.com

Finding new uses for an old drug is a noteworthy endeavor. If the drug is already approved for use in another capacity, researchers can significantly shorten the time it takes before the drug can be prescribed to patients for new applicable uses. Thus the team at St. George’s, University of London, are quite hopeful the discovery will expedite future clinical trials for cancer treatment.
 
In studying the effects of naltrexone on cancer cells, the team observed that the cells stopped growing. They also reported naltrexone altered the cells’ internal working mechanisms, causing certain genes to be turned on at higher intensity. This ultimately led to the cells killing themselves more readily, thus reducing the cancer growth.
 
"Rather than stopping the cancer cells from growing, patients want to be rid of them. We saw that by giving the drug for two days, then withdrawing it, cancer cells would stop cycling and undergo cell death," said Wai Liu, first study author.
 
Through further investigation, the team found that naltrexone selectively affected genes involved in regulating the cell cycle and the immune system. Genes that are involved with programmed cell death were also triggered by naltrexone, implicating a mechanism for the increased deaths of the cancer cells.
 
"We have shown that the genetic fingerprint of naltrexone differs according to the different doses used, which identifies new ways of using it as an anti-cancer treatment,” said Liu. The doses used in the study are much lower than what’s used in treating addiction.
 

 Naltrexone is commonly used to treat alcoholism. And as an opioid antagonist, this drug is also used to treat opioid addiction. At high doses, there’s a risk for liver damage and gastrointestinal problems.
 
And because the drug is already approved and on the market, it becomes that much more attractive. Liu, who has been researching cancer treatments for over two decades, hopes clinical trials will lead to naltrexone use in conjunction with other anticancer treatments. "We have taken a drug that is relatively safe in humans, and reformulated a new use for it; this has only been possible by understanding the dynamics of a drug. How many other drugs can be improved in this way?” asked Liu.

Additional source: MNT
 
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
DEC 02, 2019
Cancer
DEC 02, 2019
Self-renewing blood stem cells give hope for blood disease treatments
New research details how activating a certain protein may be the key to getting hematopoietic stem cells (HSCs) to self-renew. The research comes from scie...
DEC 09, 2019
Cancer
DEC 09, 2019
Hair dyes associated with increased risk of breast cancer
Research recently published in the International Journal of Cancer suggests that certain hair dyes and chemical relaxants are associated with breast cancer...
DEC 18, 2019
Drug Discovery & Development
DEC 18, 2019
A tool that simplifies the hunt for cancer drugs
Cells have long been the internal hubs for proteins that hold a wide variety of unique functions. Disorders on how a cell synthesizes a protein can affect ...
DEC 23, 2019
Cancer
DEC 23, 2019
Sustained weight loss over 50 reduces risk of breast cancer
Research published recently in the Journal of National Cancer Institute suggests a new form of cancer prevention: losing weight and keeping it off. This st...
JAN 13, 2020
Cancer
JAN 13, 2020
The anti-cancer properties of bitter melon
New research published in the journal Cell Communication and Signaling suggests that bitter melon, also known as bitter gourd, may have anti-cancer propert...
FEB 18, 2020
Cancer
FEB 18, 2020
Are you at risk of endometrial cancer?
Are you concerned about endometrial cancer? New research published recently in the Journal of Medical Genetics has identified 24 genetic variants that...
Loading Comments...